Literature DB >> 17003293

Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin.

Eva Tsalikian, Craig Kollman, William B Tamborlane, Roy W Beck, Rosanna Fiallo-Scharer, Larry Fox, Kathleen F Janz, Katrina J Ruedy, Darrell Wilson, Dongyuan Xing, Stuart A Weinzimer.   

Abstract

OBJECTIVE: Strategies for preventing hypoglycemia during exercise in children with type 1 diabetes have not been well studied. The Diabetes Research in Children Network (DirecNet) Study Group conducted a study to determine whether stopping basal insulin could reduce the frequency of hypoglycemia occurring during exercise. RESEARCH DESIGN AND METHODS: Using a randomized crossover design, 49 children 8-17 years of age with type 1 diabetes on insulin pump therapy were studied during structured exercise sessions on 2 days. On day 1, basal insulin was stopped during exercise, and on day 2 it was continued. Each exercise session, performed from approximately 4:00-5:00 p.m., consisted of four 15-min treadmill cycles at a target heart rate of 140 bpm (interspersed with three 5-min rest breaks over 75 min), followed by a 45-min observation period. Frequently sampled glucose concentrations (measured in the DirecNet Central Laboratory) were measured before, during, and after the exercise.
RESULTS: Hypoglycemia (< or = 70 mg/dl) during exercise occurred less frequently when the basal insulin was discontinued than when it was continued (16 vs. 43%; P = 0.003). Hyperglycemia (increase from baseline of > or = 20% to > or = 200 mg/dl) 45 min after the completion of exercise was more frequent without basal insulin (27 vs. 4%; P = 0.002). There were no cases of abnormal blood ketone levels.
CONCLUSIONS: Discontinuing basal insulin during exercise is an effective strategy for reducing hypoglycemia in children with type 1 diabetes, but the risk of hyperglycemia is increased.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17003293      PMCID: PMC1584283          DOI: 10.2337/dc06-0495

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  10 in total

1.  Intermittent high-intensity exercise does not increase the risk of early postexercise hypoglycemia in individuals with type 1 diabetes.

Authors:  Kym J Guelfi; Timothy W Jones; Paul A Fournier
Journal:  Diabetes Care       Date:  2005-02       Impact factor: 19.112

2.  The decline in blood glucose levels is less with intermittent high-intensity compared with moderate exercise in individuals with type 1 diabetes.

Authors:  Kym J Guelfi; Timothy W Jones; Paul A Fournier
Journal:  Diabetes Care       Date:  2005-06       Impact factor: 19.112

3.  The effects of aerobic exercise on glucose and counterregulatory hormone concentrations in children with type 1 diabetes.

Authors:  Michael J Tansey; Eva Tsalikian; Roy W Beck; Nelly Mauras; Bruce A Buckingham; Stuart A Weinzimer; Kathleen F Janz; Craig Kollman; Dongyuan Xing; Katrina J Ruedy; Michael W Steffes; Timothy M Borland; Ravinder J Singh; William V Tamborlane
Journal:  Diabetes Care       Date:  2006-01       Impact factor: 19.112

4.  Accommodating planned exercise in type I diabetic patients on intensive treatment.

Authors:  A Schiffrin; S Parikh
Journal:  Diabetes Care       Date:  1985 Jul-Aug       Impact factor: 19.112

5.  Exercise with and without an insulin pump among children and adolescents with type 1 diabetes mellitus.

Authors:  Gil Admon; Yitzhak Weinstein; Bareket Falk; Naomi Weintrob; Hadassa Benzaquen; Ragina Ofan; Gila Fayman; Levana Zigel; Naama Constantini; Moshe Phillip
Journal:  Pediatrics       Date:  2005-09       Impact factor: 7.124

6.  Evaluation and comparison of 10 glucose methods and the reference method recommended in the proposed product class standard (1974).

Authors:  R B Passey; R L Gillum; J B Fuller; F M Urry; M L Giles
Journal:  Clin Chem       Date:  1977-01       Impact factor: 8.327

7.  Accuracy of newer-generation home blood glucose meters in a Diabetes Research in Children Network (DirecNet) inpatient exercise study.

Authors:  Stuart A Weinzimer; Roy W Beck; H Peter Chase; Larry A Fox; Bruce A Buckingham; William V Tamborlane; Craig Kollman; Julie Coffey; Dongyuan Xing; Katrina J Ruedy
Journal:  Diabetes Technol Ther       Date:  2005-10       Impact factor: 6.118

8.  Adolescent patterns of physical activity differences by gender, day, and time of day.

Authors:  Russell Jago; Cheryl B Anderson; Tom Baranowski; Kathy Watson
Journal:  Am J Prev Med       Date:  2005-06       Impact factor: 5.043

9.  Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus.

Authors:  Eva Tsalikian; Nelly Mauras; Roy W Beck; William V Tamborlane; Kathleen F Janz; H Peter Chase; Tim Wysocki; Stuart A Weinzimer; Bruce A Buckingham; Craig Kollman; Dongyuan Xing; Katrina J Ruedy
Journal:  J Pediatr       Date:  2005-10       Impact factor: 4.406

10.  [Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin.

Authors:  D C Howey; R R Bowsher; R L Brunelle; J R Woodworth
Journal:  Diabetes       Date:  1994-03       Impact factor: 9.461

  10 in total
  56 in total

1.  The use of insulin pumps in youth with type 1 diabetes.

Authors:  David M Maahs; Lauren A Horton; H Peter Chase
Journal:  Diabetes Technol Ther       Date:  2010-06       Impact factor: 6.118

2.  The Effects of Basal Insulin Suspension at the Start of Exercise on Blood Glucose Levels During Continuous Versus Circuit-Based Exercise in Individuals with Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion.

Authors:  Dessi Zaharieva; Loren Yavelberg; Veronica Jamnik; Ali Cinar; Kamuran Turksoy; Michael C Riddell
Journal:  Diabetes Technol Ther       Date:  2017-06       Impact factor: 6.118

3.  Insulin pump basal adjustment for exercise in type 1 diabetes: a randomised crossover study.

Authors:  Sybil A McAuley; Jodie C Horsburgh; Glenn M Ward; André La Gerche; Judith L Gooley; Alicia J Jenkins; Richard J MacIsaac; David N O'Neal
Journal:  Diabetologia       Date:  2016-05-11       Impact factor: 10.122

Review 4.  Insulin therapy in children and adolescents with type 1 diabetes.

Authors:  Faisal S Malik; Craig E Taplin
Journal:  Paediatr Drugs       Date:  2014-04       Impact factor: 3.022

5.  Basal insulin reductions in anticipation of multiple exercise sessions in people with type 1 diabetes-a clinical perspective.

Authors:  Olivia McCarthy; Steve C Bain; Rachel Deere
Journal:  Ann Transl Med       Date:  2018-12

6.  Handling Exercise During Closed Loop Control.

Authors:  Marc D Breton
Journal:  Diabetes Technol Ther       Date:  2017-06       Impact factor: 6.118

7.  Innovations in technology for the treatment of diabetes: clinical development of the artificial pancreas (an autonomous system).

Authors:  David C Klonoff; Charles L Zimliki; Lcdr Alan Stevens; Patricia Beaston; Arleen Pinkos; Sally Y Choe; Guillermo Arreaza-Rubín; William Heetderks
Journal:  J Diabetes Sci Technol       Date:  2011-05-01

8.  Prevention of nocturnal hypoglycemia using predictive alarm algorithms and insulin pump suspension.

Authors:  Bruce Buckingham; H Peter Chase; Eyal Dassau; Erin Cobry; Paula Clinton; Victoria Gage; Kimberly Caswell; John Wilkinson; Fraser Cameron; Hyunjin Lee; B Wayne Bequette; Francis J Doyle
Journal:  Diabetes Care       Date:  2010-03-03       Impact factor: 19.112

9.  Effects of glutamine on glycemic control during and after exercise in adolescents with type 1 diabetes: a pilot study.

Authors:  Nelly Mauras; Dongyuan Xing; Larry A Fox; Kim Englert; Dominique Darmaun
Journal:  Diabetes Care       Date:  2010-06-28       Impact factor: 19.112

10.  Blunted counterregulatory hormone responses to hypoglycemia in young children and adolescents with well-controlled type 1 diabetes.

Authors:  Eva Tsalikian; William Tamborlane; Dongyuan Xing; Dorothy M Becker; Nelly Mauras; Rosanna Fiallo-Scharer; Bruce Buckingham; Stuart Weinzimer; Michael Steffes; Ravinder Singh; Roy Beck; Katrina Ruedy; Craig Kollman
Journal:  Diabetes Care       Date:  2009-08-12       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.